Joseph Rondinone

U-Systems, Inc. designs, develops, manufactures and markets ultrasound systems. The company was founded in 1997 and is headquartered in Schenectady, NY.

Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients.

Fusion Medical Technologies, Inc. is used to develop, manufactures and market surgical hemostatic products like sutures and topical agents such as sponges which are used to stop bleeding in a variety of surgeries. The Company's product floSeal (R) matrix hemostatic sealant was used to control surgical bleeding. It products were used in a variety of surgical procedures like cardiac, vascular, spinal, ear, nose, throat, head, neck and cranial surgeries. The company marketed its products through direct sales force. It was headquartered in Fremont, CA.

Laserscope, Inc. manufactures medical laser systems for surgical and aesthetic applications. Its products are used to perform treatments including the removal of leg and facial veins, unwanted hair, pseudo-folliculitis and wrinkles. Laserscope was founded by Robert J. Pressley and Rodney C. Perkins in 1982 and is headquartered in San Jose, CA.

Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL.

PneumRx, Inc. operates as a medical device company which focuses on developing minimally-invasive solutions for unmet medical needs in pulmonary medicine. Its product is a minimally invasive device intended to improve exercise capacity, lung function, and quality of life in patients with both heterogeneous and homogeneous emphysema. The company was founded by by Erin McGurk, Mark L. Mathis, and Ronald Dieck in 2004 and is headquartered in Mountain View, CA.

Asthmatx, Inc. develops catheter-based outpatient procedure that provides asthma control for adult severe asthma patients. The company was founded in 2003 and is headquartered in Sunnyvale, CA.